AstraZeneca, China
AstraZeneca faces potential fines in China
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
Lord Storey says he fears Merseyside was "not a high priority" on the government's growth agenda.
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...
AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...
Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” ...
The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million ...
FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were ...
AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback